Earnings Call · Q2 FY2022·2022-08-05

Q2 22EPS +62.50%·Rev n/aQ1 22EPS +66.67%·Rev n/aQ4 21EPS +10.00%·Rev n/aQ3 21EPS -78.57%·Rev n/a⚠ consensus missing

Alignment Healthcare, Inc. ALHC

John Kao — Founder and CEO

Thomas Freeman — Chief Financial Officer

+6.7%1d on move date+6.9% vs SPY3d+0.9%5d−4.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALHC calls or request research access.

More ALHC calls Browse calls Request research access